TrialJCI insight2018

Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover study.

Jenny E Blau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.